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Education Program using Non-Pharmacologic Support during Benzodiazepine
Reduction in Patients with Anxiety Disorders
Abstract
A private mental health clinic developed an initiative to aid patients with anxiety disorders to taper their
use of benzodiazepines. Based on best practices, a treatment protocol was developed in which patients
attended 4 sessions (1 per month) in which they combined instruction in non-pharmaceutical anti-anxiety
techniques (guided imagery, mindfulness meditation, deep breathing, progressive muscle relaxation,
exercise, emotional freedom) with cognitive behavioral therapy and use of selective serotonin re uptake
inhibitors. Participants experienced a reduction in benzodiazepine use. This small scale initiative showed
that the holistic approach to anxiety management was an effective plan to decrease the use of
benzodiazepines in the treatment of anxiety disorder.
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Introduction
Benzodiazepines are commonly used in the treatment of anxiety disorder (Cascade &
Kalai, 2008). Despite the drug’s effectiveness, the process of weaning clients off of
benzodiazepines requires that they use other types of anxiety reducing measures. Using nonpharmacologic methods provides a viable way to decrease certain types of anxiety. Nonpharmacologic measures, along with selective serotonin reuptake inhibitors (SSRIs), have been
effective with certain anxieties and could assist in reducing benzodiazepine use (Bandelow et
al., 2013). Thus, the project initiative was designed to use SSRIs and non-pharmacologic antianxiety techniques along with a support program to taper the dosage of benzodiazepines.
Background
The American Psychiatric Association (2003) roster of anxiety disorders included
Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder with or without
Agoraphobia, Phobias, Post -traumatic Stress Disorder, Acute Stress Disorder, and Anxiety
Disorder not otherwise specified. Common treatments for anxiety disorders combine therapy
and pharmacotherapy, and the drugs in use are selective serotonin reuptake Inhibitors,
selective neuroepinephrine reuptake inhibitors, and benzodiazepines (Bandelow et al., 2013).
The high rate of abuse and dependence makes it difficult for individuals to successfully
discontinue use of benzodiazepines. Chronic use nationally ranges from 2-8% of the
population, and 25%-76% of people with anxiety disorders are at risk for long- term abuse
(Bandelow et al., 2013). Some 5% have taken benzodiazepines for a period of six months or
more (Konopka, Pelka-Wysiecka, Grzywacz, & Samochowiec, 2013). Inability to cope with
stress, lack of resistance, and being unaware of coping skills contribute to dependency on
benzodiazepines and under-utilization of non-pharmacological techniques (Merikangas,
Burstein, & Schmitz, 2013). Rapid relief of anxiety symptoms and known efficacy are amongst
top reasons for use of benzodiazepines. Individuals seeking treatment often want immediate
relief for anxiety, and therefore, underutilize non-pharmacological techniques. In a study on
the discontinuation of benzodiazepines, the use of non-pharmacological techniques ― in
comparison to benzodiazepine use alone ― produces greater reduction in anxious symptoms
(Gosselin, Ladouceur, Morin, Dugas, & Baillargeon, 2006).
Non-pharmacological techniques include, but are not limited to, the following:
cognitive behavioral therapy, cognitive behavioral therapy with emotion focused,
interpersonal therapy, metacognitive therapy, exercise, mindfulness meditation, worry
exposure, applied relaxation, meditation-based stress program, healing touch, meridian
tapping, and thought field therapy. In the present initiative, the techniques selected and
implemented were as follows: guided imagery, mindfulness meditation, deep breathing,
progressive muscle relaxation, exercise, emotional freedom techniques, and cognitive
behavioral therapy.
Local Problem
In a psychiatric practice, a cadre of patients diagnosed with anxiety disorders was
deemed candidates for control of anxiety using other forms of medication and anti-anxiety
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methods. Since the practice site has no educational program in place that addresses coping
skills using non-pharmacological techniques, patients typically have rebound anxiety when
attempting to discontinue benzodiazepines, and subsequently, they resort back to its use.
Initiative Goals
The initiative was planned and designed to decrease the frequency of and taper the
use of benzodiazepines using non-pharmacological techniques and individualized support.
The aim was to educate clients in the use of non-pharmacological techniques and use these
techniques with SSRIs to replace pharmaceutical dependency within 12 weeks of such
therapy.
Ethical Issues
The project was approved by The University of Texas Health Science Center at
Houston Institutional Review Board for the Protection of Human Subjects as a quality
improvement project. Participants were assigned a number as an identifier for data
collection. Data and consent forms were stored at the practice site in locked files
independent of patient records, and names were kept confidential.
Methods
Planning the Intervention/Procedure
A clinician reviewed non-pharmacologic methods used to decrease anxiety and
evaluated evidence-based and best practices specific to non-pharmacologic stress reduction
techniques. Using this information, a nurse practitioner and the psychiatrist owner of the
practice selected the non-pharmacologic anti-anxiety techniques that would promote safe
and improved management of anxiety disorders, support recommended gold standard
treatment, and have the potential to reduce liability of the clinician due to overprescribing
benzodiazepines. The techniques used were defined as follows:
• Guided imagery entails the individual imagining being in a place of comfort, such as a
beach or tropical island, and can result in a deep state of relaxation that reduces
anxiety and fears (Jain et al., 2011).
• Mindfulness meditation encompasses meditation techniques that allow individuals to
acknowledge their feelings, emotions, mental state, and acceptance of the present
(Hoge et al., 2013). Mindfulness meditation allows a non-judgmental focus on oneself
to decrease anxiety.
• Deep breathing requires a change in breathing pattern to long and smooth
diaphragmatic breathing. Such rhythmical and diaphragmatic breathing possibly
serves as autonomic training that improves mood stabilization (Chow & Tsang, 2007).
Because individuals with anxiety disorders often have rapid and shallow breathing,
deep breathing assists with slowing down the breath.
• Emotional freedom techniques and thought field therapy involves the practitioner
tapping the patients’ hands, face, and body while they reflect on emotions, thoughts,
and past events (Irgens, Dammen, Nysæter, & Hoffart., 2012). The authors claim that
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•

•

tapping expands the body’s energy blockades and assists in returning individuals to
homeostasis between mind and body.
Progressive muscle relaxation is helpful when anxiety triggers are present (Hoyer et
al., 2009). Individuals focus on certain aspects of their body as they progressively
relax joints, muscles, and organs (Chow & Tsang, 2007). Releasing tension from the
muscles facilitates a more positive mindset.
Aerobic and resistance exercise, recommended for use 3-5 times a week in increments
of 30-60 minute sessions (Bandelow et al., 2013), improves symptoms of anxiety,
including difficulty with concentration, fatigue, insomnia, irritable mood, and
depression (Herring, Jacob, Suveg, & O’Connor, 2012).

Implementing the Initiative
The team developed a protocol titled Anxiety Reduction during Benzodiazepine
Reduction Protocol (see Appendix A). Twenty (20) patients who expressed a desired to
decrease benzodiazepine use and met the inclusion criteria for anxiety agreed to the program
protocol. Likewise, they expressed willingness to adhere to the non-pharmacologic methods.
The treatment required four visits scheduled four weeks apart, or one visit per month. The
procedure was as follows:
• In the initial visit, patients were informed about benzodiazepine use and risks as well
as the benefits of non-pharmacological techniques. Participants received written
instructions for the non-pharmacological techniques and were instructed to document
frequency of their use throughout each month, and to keep a journal of anxious
moments and triggers that may have caused anxiety.
• In the second visit, patients described improvements in their anxiety management,
noted identification of triggers, expressed whether or not non-pharmacological
techniques provided benefit, and noted the frequency of benzodiazepine use (same,
more, or less). Additionally, the patient received a referral for cognitive behavioral
therapy. A selective serotonin reuptake inhibitor (SSRI) was initiated as part of first
line treatment for anxiety disorders (if patients were not already taking a SSRI).
• In the third visit, patients reported details of their anxiety management and trigger
identification, use of non-pharmacological techniques, perceived level of anxiety, and
tolerability and side effects of the SSRI medication. They stated whether or not they
started cognitive behavioral therapy.
• In the fourth visit, the practitioner focused on anxiety management as evidenced by
continued use of non-pharmacological techniques, response to SSRI treatment,
identification triggers, and attendance of cognitive behavioral therapy sessions.
• In subsequent clinical visits following program completion, the nurse practitioner
noted verbal reports of continued use of non-pharmacological techniques and
documented such in the patients’ medical charts.
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Analysis and Outcomes
Each participant completed a questionnaire (Appendix B) that asked for the frequency
of use of non-pharmacological techniques, their perceived effectiveness, and changes in
benzodiazepine use since the start of the program. Patients also reported on which of the
non-pharmacologic techniques they found to be the most beneficial in decreasing their
anxiety.
Outcomes
As shown in Table 1, 85% (n=17) of participants reported a decrease in the use of
benzodiazepines. Chi Square analysis showed a significant difference (Chi Square 9.8, df 1, p
= .03). Three participants reported no decrease in their use of the drug. Participants were
medicated with different benzodiazepines (e.g. lorazepam, alprazolam, diazepam, and
clonazepam). Six participants who took higher doses of the benzodiazepines with a short
half- life, such as alprazolam, reported more difficulty reducing their frequency of using the
drug.
Table 1. Decreased Use of Benzodiazepines in Three Months
Frequency
Percent
Valid
Percent
0 (decrease)
3
15.0
15.0
1 (same)
17
85.0
85.0
Total
20
100.0
100.0

Cumulative
Percent
15.0
100.0

Perception of Benefit and Use of Non-Pharmacological Techniques
Of the 20 participants, 11 (55%) identified Cognitive Behavioral Therapy (CBT) as being
the most effective non-pharmacological technique to decrease stress (Table 2). Exercise was
the second most effective technique reported, with mindfulness being third, and progressive
muscle relaxation, fourth. Participants reported emotional freedom techniques were more
complex to use, as compared to techniques such as guided imagery and deep breathing.
Table 2. Non-pharmacological Techniques Most Beneficial in Managing Anxiety
Number
Percentage
Guided Imagery
n=0
0%
Deep breathing
n=0
0%
Cognitive Behavioral Therapy
n=11
55%
Exercise
n=4
20%
Emotional freedom techniques
n=0
0%
Mindfulness meditation
n=3
15%
Progressive muscle relaxation
n=2
10%
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In terms of the frequency of use of non-pharmacological techniques (Table 3),
participants were more likely to use deep breathing on a daily basis, while exercise more
likely occurred two to three days a week. Patients attending cognitive behavioral therapy
sessions mostly did so weekly to every two weeks, depending upon the severity of their
anxiety. Participants reported initially seeing the psychologist often, but varied in how often
they visited throughout the three months. Some participants felt this activity was helpful but
time consuming. Two participants stated that the psychologist listened to their worries, but
did not offer advice or insight.
Table 3. Frequency of Use of Non-Pharmaceutical Techniques
Technique
Guided Imagery

N
20

Minimum
1

Maximum
5

Mean
2.95

SD
1.538

Deep Breathing

20

1

5

3.40

1.569

Cognitive
Behavioral Therapy
Exercise
Emotional Freedom
Techniques
Mindfulness
Meditation
Progressive Muscle
Relaxation
Valid n (listwise)

20

1

5

3.75

1.446

20
20

2
1

5
5

3.85
2.75

1.089
1.446

20

1

5

3.40

1.353

20

1

5

3.10

1.373

20

Fifteen participants (75%) reported three months was a sufficient amount of time for
the individualized program, while five participants (25%) thought it was not long enough. Five
participants (25%) recommended changes to the program and suggested increasing the length,
adding more non-pharmacological techniques, extending appointment times to more than
once monthly, and adding group therapy sessions.
All participants reported feeling better emotionally and being able to deal with life
stressors more effectively. Five participants at the end of the initiative noted that they
thought more clearly and could concentrate on the task at hand. Four participants reported
that irrational fears decreased. Overall, participants were able to face some triggers of
anxiety symptoms once their irrational fears decreased. All participants (100%) reported that
(1) using non-pharmacological techniques improved anxiety management, and (2) they were
likely to continue using the techniques after the program.
Follow-up after 3 Sessions
During subsequent follow up visits following program completion, the nurse
practitioner documented their continued experiences with using the techniques in their
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medical charts. The majority of the participants verbally reported a decrease in
benzodiazepine reliance and felt they had more control over their life.
Limitations during Initiative Implementation
A difficulty encountered was missed and rescheduled appointments. However, the
nurse practitioner urged patients to reschedule within the same week. In addition, some
patients found it difficult to keep a journal of stressful moments and document their anxiety.
However, those who did stated that journaling helped to identify the cause of certain anxiety
triggers.
Because cognitive behavioral therapy was provided by psychologists outside of the
clinic, it was difficult to track the details of what took place during the sessions. In addition,
the level of severity of anxiety varied among the participants, which often dictated the
frequency of visits per person. Exercise was a difficult non-pharmacological technique to
measure. Participants choose different methods, and each participant’s number of days
exercised varied as well as the length of time expended. Some participants reported
exercising previous to the protocol, which may have affected overall anxiety management
and explained why they were neutral or disagreed as to the benefit of exercise being
beneficial in the questionnaire.
Relation to Other Evidence
Gosselin et al., (2006) found that slow tapering of benzodiazepine dosage in
conjunction with cognitive behavioral therapy was an efficacious long term activity for
achieving complete cessation. The present initiative found that relapse of benzodiazepine use
was less in adults that had a non-pharmacological program in place to assist with tapering.
Voshaar et al. (2008) reported long term taper success is more likely to be achieved if
a taper program is offered and patients remain actively in treatment. The authors noted that
the outcome of the taper is related to current dosage and the patient’s willingness to reduce
the dosage. In the present initiative, participants were urged to follow up monthly, and they
were encouraged to remain in treatment after the intervention ended.
Herring et al (2011) found that physical exercise produced rapid results as evidenced
by subjective reporting of decrease of anxiety symptoms within six weeks. Participants in
this study reported exercise assisted with decreasing stress and anxiety overall.
Interpretation
The protocol was expected to provide participants with alternative techniques to
manage anxiety as well as assist them as they decreased their benzodiazepine regimen.
Modifications to improve the protocol would be to provide participants with additional nonpharmacological techniques such as applied relaxation, worry exposure, and interpersonal
therapy. The protocol was appropriate for implementation in a private practice setting that
specialized in mental health. The outcome for the first implementation cycle of the project
showed that there was a decrease in patient’s use of benzodiazepines and the patients were
consistent in their use of non-pharmacologic techniques. Outcomes were favorable in that

https://digitalcommons.library.tmc.edu/uthoustonjqualsafe/vol1/iss2/1

6

Kearney and Wardell: Educational Program to Support Benzodiazepine Reduction for Anxiety

using non-pharmacological techniques was beneficial in managing anxiety symptoms along
with reduced benzodiazepine use.
Application to Practice
The current flow of appointments in the primary care setting focuses on medication
management. The clinician assesses the patient’s response to medication, including their
side effects and effect on mood and sleep. By incorporating the Anxiety Reduction during
Benzodiazepine Protocol, patient management of anxiety shifts from a regimen that is solely
dependent on benzodiazepines to a holistic approach that includes non-pharmacological
techniques. An advantage gained is that this approach may help reduce provider liability by
reducing the number of benzodiazepines prescribed.
A barrier to implementing the Anxiety Reduction during Benzodiazepine Protocol in
practice might be insufficient time to meet with the patients given a usual daily patient load.
Reducing the number of patients seen daily to extend the allotted time for appointments is
problematic. However, to adjust for extension of patient appointments, judicious use could
be made of reimbursement and time codes. For example, the CPT code 99214 can be used
for problems of moderate severity and/or visits that are at least 25 minutes, and CPT code
99215 can be used for problems of moderate to high severity and/or visits that are at least 40
minutes. It should be noted that each insurance panel reimburses at different rates according
to coding and billing. Sustaining the protocol in practice is possible if the clinician has
adequate time to teach non-pharmacological techniques and code higher reimbursement
codes to compensate for seeing fewer patients.
Discussion
Health care providers carry the responsibility for educating patients about the risks
and benefits of prescribing benzodiazepines for individuals diagnosed with anxiety disorders.
One study found that although benzodiazepines are proven to provide relief of anxiety
symptoms, they should be administered short term (Kurihara, 2007). Mental health
professionals should provide guidance in helping patients to label triggers that may lead to
relapse (Parr. Kavanagh, Cahill, Mitchell, & Young, 2008). Providing education, tools, and
referrals for utilization of non-pharmacological techniques are essential when tapering
benzodiazepines.
A protocol to provide support while discontinuing benzodiazepines may be more
successful than gradual dosage reduction alone (Parr et al, 2008). A protocol provides
individuals with alternatives for managing anxiety while the benzodiazepine dose is
decreased. Clinicians will need to enforce a strict policy in their practice to ensure a
continuous prescription of benzodiazepines is not being supplied.
Based on the outcomes of this initiative, more emphasis could be placed on identifying
triggers and on providing access to first line treatment, such as Cognitive Behavioral Therapy.
The nurse practitioner could also focus on other exercise regimens shown to be effective in
reducing anxiety, such as yoga. Emotional freedom techniques probably would need referral
to a trained provider to reinforce the technique for better utilization or not be included as it
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was seen as too complex. Benefits in the use of non-pharmaceutical techniques could be
obtained by allowing the patients to self-select the techniques they wish to practice.
Conclusion
The Anxiety Reduction during Benzodiazepine Protocol helped participants identify
triggers and stressors that increased severity and duration of anxiety symptoms. The use of
stress reduction techniques and a focused program to change the medications taken for
anxiety showed promise in achieving the goal of decreasing benzodiazepine use and anxiety.
A holistic approach to anxiety management is likely to be more appropriate than a treatment
plan that is solely based on anxiolytics. Health care providers can educate patients about the
risks associated with benzodiazepines, provide support when tapering, and prescribe
benzodiazepines as short-term treatment. Selective serotonin reuptake inhibitors can be
utilized as a first line treatment. Implementation of the protocol can be effective in reducing
Benzodiazepine use, support the use of non-pharmacological techniques, decrease
physiological and psychological symptoms of anxiety, and successfully reduce benzodiazepine
use.

References
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental
Disorders: DSM-5. Washington, DC: Author.
Bandelow, B., Boerner, R. J., Kasper, S., Linden, M., Wittchen, H.-U., & Möller, H.-J. (2013).
The Diagnosis and Treatment of Generalized Anxiety Disorder. Deutsches Aerzteblatt
International, 110(17), 300-310. doi: 10.3238/arztebl.2013.0300
Cascade, E. & Kalal, A. H. (2008). Use of benzodiazepines in the treatment of anxiety.
Psychiatry (Edgmont), 5(9), 21.
Chow, Y., & Tsang, H. (2007). Biopsychosocial effects of qigong as a mindful exercise for
people with anxiety disorders: A speculative review. Journal of Alternative &
Complementary Medicine, 13(8), 831-839. doi:10.1089/acm.2007.7166
Gosselin, P., Ladouceur, R., Morin, C., Dugas, M. & Baillargeon, L. (2006). Benzodiazepine
discontinuation among adults with GAD: A randomized trial of cognitive behavioral
therapy. Journal of Counseling and Clinical Psychology,75(5), 908-919. doi:
10.1037/0022-006x.74.5.908
Herring, M., Jacob, M., Suveg, C. & O’Connor, P. (2012). Feasibility of exercise training for
the short-term treatment of generalized anxiety disorder: A randomized controlled
trial. Journal of Psychotherapy and Psychosomatic,81(1),8-21. doi: 10.1159/000327898
Hoge, E., Bui, E., Marques, L., Metcalf., C., Morris, L., Robinaugh, D., … Simon, N. (2013).
Randomized controlled trial of mindfulness meditation for generalized anxiety
disorder: Effects on anxiety and stress reactivity. Journal of Clinical Psychiatry,74(8),
786-792.

https://digitalcommons.library.tmc.edu/uthoustonjqualsafe/vol1/iss2/1

8

Kearney and Wardell: Educational Program to Support Benzodiazepine Reduction for Anxiety

Hoyer, J., Beesdo, K., Gloster, A. T., Runge, J., Höfler, M., & Becker, E. S. (2009). Worry
exposure versus applied relaxation in the treatment of generalized anxiety disorder.
Psychotherapy & Psychosomatics, 78(2), 106-115. doi: 10.1159/000201936
Irgens, A., Dammen, T., Nysæter, T.E., & Hoffart, A. (2012). Thought Field Therapy (TFT) as
a treatment for anxiety symptoms: A randomized controlled trial. Explore (New York,
N.Y.), 8(6), 331-338.
Jain, S., McMahon, G., Hasen, P., Kozub, M., Porter, V., King, R. & Guarneri, E. (2012).
Healing touch with guided imagery for PTSD in returning active duty military: A
randomized controlled trial. Journal of Military Medicine, 177(9), 1015-1021.
Konopka, A., Pelka-Wysiecka, J., Grzywacz, A., & Samochowiec, J. (2013). Psychosocial
characteristics of benzodiazepine addicts compared to not addicted benzodiazepine
users. Journal of Neuro-Psychopharmacology & Biological Psychiatry, 40, 229-235.
Kurihara, T. (2007). More rational use of benzodiazepines in the outpatient. Journal of
Japanese Society of Internal Medicine, 255-256. doi:
10.2169/internalmedicine.46.0172
Merikangas, R., Burstein, M., & Schmitz, A. (2013). Anxiety disorders in women. Women and
Health (pp.1257-1265). Bethesda, MD: National Institute of Mental Health, Genetic
Epidemiology Research Branch.
Parr, J.M., Kavanagh, D.J., Cahill. L, Mitchell., G, & Young, R. (2008). Effectiveness of
current treatment approaches for benzodiazepine discontinuation: A meta analysis.
Journal of Addiction, 104, 13-24. doi: 10.1111/j.1360-0443.2008.02364x
Voshaar, R., Gorgels, W., Mol, A., Van Balkom, E., Van de Lisdonk, E., Breteler, M. & Zitman,
F. (2006). Predictors of long-term benzodiazepine abstinence in participants of a
randomized controlled benzodiazepine withdrawal program. The Canadian Journal of
Psychiatry, 55, 445-452.

Published by the Baylor College of Medicine, Division of Academic General Pediatrics, 2017

9

Journal of Nursing & Interprofessional Leadership in Quality & Safety, Vol. 1, Iss. 2 [2017], Art. 1

Appendix A.
Anxiety Reduction during Benzodiazepine Reduction Protocol
Choice of patients in practice
Patients diagnosed with an anxiety disorder who desire to reduce frequency of
benzodiazepine usage.
1) Inclusion criteria for benzodiazepine reduction protocol
a) Age 18 and older
b) Diagnosed with an anxiety disorder, including anxiety disorder not otherwise specified,
generalized anxiety disorder, obsessive -compulsive disorder, and panic disorder with
or without agoraphobia, and social anxiety disorder.
c) Currently using benzodiazepines for anxiety episodes (?) – or just anxiety
d) identified as having difficulty decreasing benzodiazepine usage
e) No present use of non-pharmacologic anxiety reducing techniques
f) Candidate for use of Selective Serotonin Reuptake Inhibitors
2) Willing to use non-pharmacologic anxiety decreasing techniques
3) Agree to participating in Cognitive Behavioral Therapy
4) Agree to 4 individual visits as per the program protocol
Initial visit:
1. Educate participants about the benefits and risks of taking benzodiazepines.

2. Discuss possible withdrawal symptoms if benzodiazepines are discontinued abruptly.
3. If potential participant agrees, then the NP will:
a. Educate participants about usage of non-pharmacological techniques including
Cognitive Behavioral Therapy, Emotional Freedom Techniques, Progressive Muscle
Relaxation, Guided Imagery, Deep Breathing, Mindfulness Meditation, and benefits of
exercise.
b. Refer patient to a therapist to initiate Cognitive Behavioral Therapy.
c. Provide participants with handouts including
1. benzodiazepine education,
2. identification of anxiety triggers
3. Types of non-pharmacological techniques
4. Form to document of frequency of benzodiazepine usage.
4. Initiation or continuation of Selective Serotonin Reuptake Inhibitors
First follow up visit (4 weeks after 1st visit):
1. Participant will report verbally which non-pharmacological techniques seem to be more
effective.
2. Participant will report verbally perception of symptom management of anxiety.
3. Follow up to confirm if patient initiated CBT.
4. Provide emotional support for anxiety management.
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5. Assist patient in the identification of triggers, and how triggers are being managed
6. Evaluate response to Selective Serotonin Reuptake Inhibitors
Second follow up visit (8 weeks after program implementation):
1. Participant report verbally if anxiety symptom management is improving.
2. Participant report which non-pharmacological techniques seem to be more effective.
3. Provide emotional support for anxiety management.
4. Follow up with patient to determine progress with initiation of CBT.
5. Evaluate response to Selective Serotonin Reuptake Inhibitors
Third visit (3 months, final visit) the NP will:
1. Address any questions or concerns participants’ have about Benzodiazepine Reduction
Protocol.
2. Patient completes questionnaire to evaluate effectiveness of the protocol.
3. Encourage patient to continue with CBT and utilization of other non-pharmacological
techniques used.
4. Discuss with patient the termination of the protocol, and participant will continue as a
patient at the practice.
5. Evaluate response to Selective Serotonin Reuptake Inhibitors
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Appendix B.
Questionnaire for Evaluation of Benzodiazepine Reduction Protocol
1. Which non-pharmacological technique did you find most beneficial in managing anxiety
symptoms?
2. Which non-pharmacological technique did you find least beneficial in managing anxiety
symptoms?
3. In the table below, rate the level of effectiveness for each non-pharmacological
technique by checking the most appropriate box.
Table 1

Strongly
Disagree
(1)

Disagree

Neutral

Agree

(2)

(3)

(4)

Strongly
Agree
(5)

Guided Imagery
Deep Breathing
Cognitive Behavioral
Therapy
Exercise
Emotional Freedom
Techniques
Mindfulness Meditation

4. In the table below, please indicate the frequency of using non-pharmacological techniques
by checking the most appropriate box.
Table 2

Rarely
(1)

Every two
weeks
(2)

Weekly
(3)

2-3 times
weekly
(4)

Once daily
(5)

Guided Imagery
Deep Breathing
Cognitive Behavioral
Therapy
Exercise
Emotional Freedom
Techniques
Mindfulness Meditation
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5. In your opinion, did the use of non-pharmacological techniques help to better manage
anxiety? Please give an example.
e.g. Guided imagery was used by imagining myself on a tropical island when I experienced
worry and intrusive negative thoughts, and, consequently, the anxious thoughts slowed down.
6. Did you decrease the use of benzodiazepines within the past three months?
7. Are you likely to continue using non-pharmacological techniques after the program?
8. Is three months a sufficient amount of time to implement the protocol?
9. Do you recommend any additions or changes to the protocol? If so, please list needed
change
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